AMENDMENT OF EMPLOYMENT AGREEMENTEmployment Agreement • April 30th, 2018 • Therapix Biosciences Ltd. • Pharmaceutical preparations
This Amendment (the “Amendment”) is made and entered into on March, 2018, by and between Therapix Biosciences Ltd., a public company organized under the laws of the State of Israel (the “Company”), and Dr. Adi Zuloff-Shani, Israeli I.D No. [*] (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 30th, 2018 • Therapix Biosciences Ltd. • Pharmaceutical preparations
THIS PERSONAL EMPLOYMENT AGREEMENT (the “Agreement”) is made this 19 day of July 2017, by and between Therapix Biosciences Ltd. registry number 513581652 a company having its principal place of business at 5 Azrieli Center (Square Tower) 27 Fl. Tel-Aviv 6702501, Israel (the “Company”), and Oz Adler (I.D. No. [*]) of [*] (the “Employee”).
AMENDMENT OF EMPLOYMENT AGREEMENTEmployment Agreement • April 30th, 2018 • Therapix Biosciences Ltd. • Pharmaceutical preparations
This Amendment (the “Amendment”) is made and entered into on this 1day of March, 2018 (the “Effective Date”), by and between Therapix Biosciences Ltd., a public company organized under the laws of the State of Israel (the “Company”), and Oz Adler, Israeli I.D No. [*] (the “Employee”).
SECOND AMENDMENT TO LICENSE AGREEMENTLicense Agreement • April 30th, 2018 • Therapix Biosciences Ltd. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO LICENSE AGREEMENT (the “Second Amendment”) is made as of September 17, 2017 by and between Dekel Pharmaceuticals Ltd. (the “Licensor” or “Dekel”), and Therapix Biosciences Ltd., (the “Licensee” or “Therapix”). Licensee, on the one hand, and Licensor, on the other, may each individually be referred to in this Amendment as a “Party” and collectively referred to in this Amendment as the “Parties”.
Separation AgreementSeparation Agreement • April 30th, 2018 • Therapix Biosciences Ltd. • Pharmaceutical preparations
By and between Therapix Biosciences Ltd., 4 Ariel Sharon, Hashachar Tower, Givatayim, Israel (the “Company”), and Josh Blacher, [*] (the “Employee”), dated this 19th day of December, 2017.
